Connection

Angelo Avogaro to Aged

This is a "connection" page, showing publications Angelo Avogaro has written about Aged.
Connection Strength

0.149
  1. Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: A case-control study. Diabetes Obes Metab. 2020 10; 22(10):1946-1950.
    View in: PubMed
    Score: 0.016
  2. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020 06; 43(6):867-869.
    View in: PubMed
    Score: 0.016
  3. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study. J Am Heart Assoc. 2019 07 16; 8(14):e012244.
    View in: PubMed
    Score: 0.015
  4. p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications. Cardiovasc Diabetol. 2018 01 17; 17(1):16.
    View in: PubMed
    Score: 0.013
  5. Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial. Cardiovasc Diabetol. 2017 04 04; 16(1):42.
    View in: PubMed
    Score: 0.013
  6. The role of point-of-care 3-hydroxybutyrate testing in patients with type 2 diabetes undergoing coronary angiography. J Endocrinol Invest. 2017 Jun; 40(6):627-634.
    View in: PubMed
    Score: 0.013
  7. Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes. J Clin Endocrinol Metab. 2016 Feb; 101(2):748-56.
    View in: PubMed
    Score: 0.012
  8. Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown. Nutr Diabetes. 2021 01 05; 11(1):1.
    View in: PubMed
    Score: 0.004
  9. Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis. Intern Emerg Med. 2021 Mar; 16(2):419-427.
    View in: PubMed
    Score: 0.004
  10. The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience. J Thromb Haemost. 2020 Oct; 18(10):2629-2635.
    View in: PubMed
    Score: 0.004
  11. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res Clin Pract. 2020 Oct; 168:108374.
    View in: PubMed
    Score: 0.004
  12. Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2019; 7(1):e000725.
    View in: PubMed
    Score: 0.004
  13. Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study. Diabetes Obes Metab. 2019 11; 21(11):2542-2552.
    View in: PubMed
    Score: 0.004
  14. Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes. J Clin Endocrinol Metab. 2018 10 01; 103(10):3773-3782.
    View in: PubMed
    Score: 0.004
  15. Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study. Diabetes Obes Metab. 2019 02; 21(2):252-260.
    View in: PubMed
    Score: 0.004
  16. Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study. Diabetes Obes Metab. 2018 07; 20(7):1781-1786.
    View in: PubMed
    Score: 0.003
  17. Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events. Diabetes Metab. 2018 Sep; 44(4):333-340.
    View in: PubMed
    Score: 0.003
  18. Intraclass differences in the risk of hospitalization for heart failure among patients with type 2 diabetes initiating a dipeptidyl peptidase-4 inhibitor or a sulphonylurea: Results from the OsMed Health-DB registry. Diabetes Obes Metab. 2017 10; 19(10):1416-1424.
    View in: PubMed
    Score: 0.003
  19. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy. J Diabetes Complications. 2017 Aug; 31(8):1348-1353.
    View in: PubMed
    Score: 0.003
  20. Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study. J Diabetes Complications. 2017 Jun; 31(6):952-957.
    View in: PubMed
    Score: 0.003
  21. Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance. Atherosclerosis. 2017 06; 261:117-123.
    View in: PubMed
    Score: 0.003
  22. Integrated kinematics-kinetics-plantar pressure data analysis: a useful tool for characterizing diabetic foot biomechanics. Gait Posture. 2012 May; 36(1):20-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.